×

Medicament For the Treatment of Central Nervous System Disorders

  • US 20080194631A1
  • Filed: 07/26/2005
  • Published: 08/14/2008
  • Est. Priority Date: 07/26/2004
  • Status: Abandoned Application
First Claim
Patent Images

1. The use of a molecule, alone or in combination, chosen from the group of molecules having a simultaneous antagonist action on the alpha1-noradrenergic, glutamatergic NMDA and serotoninergic 5HT2 receptors, for the preparation of a medicament intended for treating pathologies of the central nervous system.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×